Research tools
Analyst Ratings Screener
Find recent upgrades, downgrades, initiations, and reiterations by firm, rating, consensus, target upside, sector, and company size.
Save your best screens
Sign in to keep filters and sorting ready for your next visit.
4,357 matching rating changes
Export CSV| Date, sort lowest first | Symbol | Company | Firm | Action | Prior rating | New rating | Consensus | Analysts, sort highest first | Avg. target | Target upside, sort highest first | Market cap, sort highest first |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | IONS | Ionis Pharmaceuticals, Inc. | Barclays | Main | Overweight | Overweight | — | — | $83.85 | +50.67% | 12.57B |
| Sep 9, 2026 | IRD | Opus Genetics, Inc. | Chardan Capital | Main | Buy | Buy | — | — | $7.00 | +15.32% | 167.86M |
| Sep 9, 2026 | IRD | Opus Genetics, Inc. | HC Wainwright & Co. | Reiterated | Buy | Buy | — | — | $7.00 | +15.32% | 167.86M |
| Sep 9, 2026 | IRD | Opus Genetics, Inc. | BTIG | Reiterated | Buy | Buy | — | — | $7.00 | +15.32% | 167.86M |
| Sep 9, 2026 | IRD | Opus Genetics, Inc. | Oppenheimer | Main | Outperform | Outperform | — | — | $7.00 | +15.32% | 167.86M |
| Sep 9, 2026 | IVZ | Invesco Ltd. | Evercore ISI Group | Main | In-Line | In-Line | — | — | $24.94 | -21.89% | 12.01B |
| Sep 9, 2026 | JILL | J.Jill, Inc. | BTIG | Main | Buy | Buy | — | — | $18.33 | -19.50% | 162.61M |
| Sep 9, 2026 | KDK | Kodiak AI, Inc. Common Stock | Chardan Capital | Main | Buy | Buy | — | — | $17.33 | +356.05% | 1.5B |
| Sep 9, 2026 | KDK | Kodiak AI, Inc. Common Stock | Needham | Initiated | — | Buy | — | — | $17.33 | +356.05% | 1.5B |
| Sep 9, 2026 | LFST | LifeStance Health Group, Inc. | Canaccord Genuity | Main | Buy | Buy | Buy | 15 | $8.00 | -38.46% | 2.63B |
| Sep 9, 2026 | LINE | Lineage, Inc. | Morgan Stanley | Upgrade | Equal-Weight | Overweight | — | — | $43.44 | +16.18% | 8.45B |
| Sep 9, 2026 | LOW | Lowe's Companies, Inc. | Evercore ISI Group | Main | In-Line | In-Line | Buy | 23 | $274.33 | +39.57% | 139.18B |
| Sep 9, 2026 | LOW | Lowe's Companies, Inc. | Bernstein | Main | Outperform | Outperform | Buy | 23 | $274.33 | +39.57% | 139.18B |
| Sep 9, 2026 | LULU | Lululemon Athletica Inc. | BMO Capital | Initiated | — | Underperform | Hold | 39 | $190.78 | +96.92% | 21.22B |
| Sep 9, 2026 | LULU | Lululemon Athletica Inc. | Citigroup | Main | Neutral | Neutral | Hold | 39 | $190.78 | +96.92% | 21.22B |
| Sep 9, 2026 | LYFT | Lyft, Inc. | Scotiabank | Initiated | — | Sector Perform | — | — | $22.25 | +48.14% | 8.19B |
| Sep 9, 2026 | MGNI | Magnite, Inc. | BTIG | Reiterated | Buy | Buy | — | — | $30.00 | +27.39% | 2.27B |
| Sep 9, 2026 | MLM | Martin Marietta Materials, Inc. | Wells Fargo | Upgrade | Equal-Weight | Overweight | — | — | $678.00 | +34.93% | 38.12B |
| Sep 9, 2026 | MRK | Merck & Co., Inc. | Leerink Partners | Main | Outperform | Outperform | Buy | 20 | $112.00 | -22.60% | 248.84B |
| Sep 9, 2026 | MTZ | MasTec, Inc. | Piper Sandler | Initiated | — | Overweight | — | — | $237.60 | +2.33% | 18.38B |
| Sep 9, 2026 | MYGN | Myriad Genetics, Inc. | UBS | Main | Neutral | Neutral | — | — | $8.00 | +138.10% | 680.86M |
| Sep 9, 2026 | NAUT | Nautilus Biotechnology, Inc. | Leerink Partners | Initiated | — | Outperform | — | — | $2.50 | +152.63% | 250.72M |
| Sep 9, 2026 | NBIS | Nebius Group N.V. | Truist Securities | Initiated | — | Buy | — | — | $115.00 | -49.59% | 22.62B |
| Sep 9, 2026 | NEM | Newmont Corporation | Bernstein | Main | Outperform | Outperform | Buy | 12 | $104.26 | -17.35% | 108.47B |
| Sep 9, 2026 | NKE | NIKE, Inc. | BMO Capital | Initiated | — | Underperform | Hold | 25 | $84.18 | +129.87% | 100.15B |
| Sep 9, 2026 | NKTR | Nektar Therapeutics | BTIG | Reiterated | Buy | Buy | — | — | $121.00 | +71.27% | 1.04B |
| Sep 9, 2026 | NTLA | Intellia Therapeutics, Inc. | Citizens | Reiterated | Market Outperform | Market Outperform | — | — | $18.69 | +56.66% | 1B |
| Sep 9, 2026 | NTLA | Intellia Therapeutics, Inc. | Wedbush | Main | Neutral | Neutral | — | — | $18.69 | +56.66% | 1B |
| Sep 9, 2026 | NTLA | Intellia Therapeutics, Inc. | HC Wainwright & Co. | Reiterated | Buy | Buy | — | — | $18.69 | +56.66% | 1B |
| Sep 9, 2026 | NTRA | Natera, Inc. | UBS | Main | Buy | Buy | Buy | 27 | $232.00 | -28.86% | 31.89B |
| Sep 9, 2026 | NUE | Nucor Corporation | JP Morgan | Main | Overweight | Overweight | Buy | 21 | $160.00 | -37.37% | 38.12B |
| Sep 9, 2026 | NWE | Northwestern Energy Group Inc | JP Morgan | Main | Neutral | Neutral | — | — | $59.50 | -15.01% | 4.17B |
| Sep 9, 2026 | NXT | Nextpower Inc. | Piper Sandler | Initiated | — | Overweight | — | — | $101.62 | +24.92% | 13.87B |
| Sep 9, 2026 | OGE | OGE Energy Corp. | JP Morgan | Main | Overweight | Overweight | — | — | $49.33 | +5.88% | 8.58B |
| Sep 9, 2026 | OKE | ONEOK, Inc. | Morgan Stanley | Main | Equal-Weight | Equal-Weight | Hold | 13 | $86.50 | -9.63% | 46.33B |
| Sep 9, 2026 | OKLO | Oklo Inc. | Piper Sandler | Initiated | — | Overweight | — | — | $120.50 | +202.16% | 16.1B |
| Sep 9, 2026 | ONON | On Holding AG | BMO Capital | Initiated | — | Market Perform | — | — | $58.00 | +116.01% | 16.22B |
| Sep 9, 2026 | ORA | Ormat Technologies, Inc. | JP Morgan | Main | Neutral | Neutral | — | — | $119.25 | +23.38% | 6.99B |
| Sep 9, 2026 | ORA | Ormat Technologies, Inc. | Oppenheimer | Main | Outperform | Outperform | — | — | $119.25 | +23.38% | 6.99B |
| Sep 9, 2026 | ORA | Ormat Technologies, Inc. | RBC Capital | Reiterated | Outperform | Outperform | — | — | $119.25 | +23.38% | 6.99B |
| Sep 9, 2026 | ORCL | Oracle Corporation | Scotiabank | Main | Sector Outperform | Sector Outperform | Buy | 32 | $319.08 | +108.32% | 560.97B |
| Sep 9, 2026 | ORCL | Oracle Corporation | Citizens | Reiterated | Market Outperform | Market Outperform | Buy | 32 | $319.08 | +108.32% | 560.97B |
| Sep 9, 2026 | PAYX | Paychex, Inc. | Wells Fargo | Main | Underweight | Underweight | Hold | 8 | $133.33 | +15.76% | 41.29B |
| Sep 9, 2026 | PAYX | Paychex, Inc. | Stifel | Main | Hold | Hold | Hold | 8 | $133.33 | +15.76% | 41.29B |
| Sep 9, 2026 | PCRX | Pacira BioSciences, Inc. | Leerink Partners | Initiated | — | Market Perform | Buy | 13 | $27.00 | +7.31% | 1.17B |
| Sep 9, 2026 | PEPG | PepGen Inc. | HC Wainwright & Co. | Reiterated | Buy | Buy | — | — | $13.00 | +330.46% | 395.24M |
| Sep 9, 2026 | PHVS | Pharvaris N.V. | Leerink Partners | Main | Outperform | Outperform | — | — | $45.60 | +21.57% | 1.56B |
| Sep 9, 2026 | PHVS | Pharvaris N.V. | Morgan Stanley | Main | Overweight | Overweight | — | — | $45.60 | +21.57% | 1.56B |
| Sep 9, 2026 | PHVS | Pharvaris N.V. | Wells Fargo | Main | Overweight | Overweight | — | — | $45.60 | +21.57% | 1.56B |
| Sep 9, 2026 | PHVS | Pharvaris N.V. | Citizens | Main | Market Outperform | Market Outperform | — | — | $45.60 | +21.57% | 1.56B |
